Chemical manufacturer
Comprehensive tax reform; global competitiveness for U.S. businesses; extending R&D tax credits; CFC look-through provision; duty suspension. FDA over the counter drug approval process.
TAX - Taxation/Internal Revenue Code MED - Medical/Disease Research/Clinical Labs
135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 135 - Food & Drug Administration (FDA) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
HOLLAND & KNIGHT LLP
800 17th Street NW, Suite 1100, Washington, DC, 20006, US
RICHARD M GOLD KERRY FEEHERY KATHRYN H LEHMAN JOEL ROBERSON MICHAEL WERNER